Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ninsipapogene sibarnarepvec by Hookipa Pharma for Oropharyngeal Cancer: Likelihood of Approval
Ninsipapogene sibarnarepvec is under clinical development by Hookipa Pharma and currently in Phase II for Oropharyngeal Cancer. According to GlobalData,...
Data Insights
Ninsipapogene sibarnarepvec by Hookipa Pharma for Squamous Cell Carcinoma: Likelihood of Approval
Ninsipapogene sibarnarepvec is under clinical development by Hookipa Pharma and currently in Phase II for Squamous Cell Carcinoma. According to...